Back to normal; serological testing for COVID‐19 diagnosis unveils missed infections

Background The gold standard for coronavirus disease (COVID‐19) diagnosis has been the detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) RNA by nucleic acid amplification testing (NAAT). On the other hand, serological testing for COVID‐19 may offer advantages in detecting pos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2021-07, Vol.93 (7), p.4549-4552
Hauptverfasser:	Tsuchida, Tomoya, Nitahara, Yuko, Suzuki, Shotaro, Komase, Yuko, Candray, Katherine, Kido, Yasutoshi, Nakagama, Yu, Yamasaki, Yukitaka, Imamura, Mitsuru, Kawahata, Kimito, Kunishima, Hiroyuki, Fujitani, Shigeki, Mineshita, Masamichi, Matsuda, Takahide
Format:	Artikel
Sprache:	eng
Schlagworte:	Algorithms Coronaviruses COVID-19 Diagnosis Immunofluorescence immunoglobulin Immunoglobulin G Immunoglobulin M Infections Infectious diseases Nucleic acids Nucleocapsids Pneumonia Proteins Respiratory diseases SARS‐CoV‐2 Seroconversion serologic tests Serology Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Short Communication Short Communications Spike protein Viral diseases viral tropism Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!